ER

Edward Rudnic

Chief Operating Officer

Maxwell Biosciences

Georgetown, Texas


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Maxwell Biosciences
Industry
research
Employees
22.0
Seniority
C suite
Total Funding
10800000.0
Latest Funding
Seed

Technologies

Cloudflare DNS Gmail Google Apps YouTube Google Analytics Squarespace ECommerce Mobile Friendly Google Tag Manager Typekit Android Remote Circle Python

Keywords

biotechnology research biotechnology anti-infective drugs synthetic immune system claromer technology broad spectrum therapy antimicrobial peptides biodefense solutions health span extension pathogen-agnostic treatment viral infections bacterial infections fungal infections peptidomimetics preclinical studies drug development immune system restoration human clinical trials stabilized peptides biostable compounds drug candidate safety pathogen resistance immunosenescence biomimetic therapeutics antimicrobial resistance nano-therapeutics drug discovery platform broad-spectrum antivirals respiratory viruses chronic sinusitis treatment biofilm infections safety profiles viral membrane disruption infectious disease therapy peptide-mimetic drugs ll-37 mimics patent-protected technology fda approval pathway synthetic small molecules tissue penetration anti-inflammatory agents mechanism of action human trials infectious disease control clinical research collaborations biopharmaceutical innovations healthcare solutions affordable medications protocol-driven therapies infectious disease management

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans